Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
1498.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
+119%
0.03
vs -0.17
Q4.20
+108%
0.05
vs -0.66
Q2.21
-7%
0.03
vs 0.03
Q4.21
N/A
-0.34
vs 0.05
Q2.22
N/A
-0.10
vs 0.03
Q4.22
N/A
-0.20
vs -0.34
Q2.23
N/A
-0.10
vs -0.10
Q4.23
N/A
-0.17
vs -0.20
Q2.24
N/A
-0.05
vs -0.10
Q4.24
N/A
-0.04
vs -0.17
Sales Growth
YoY
Current
Estimates
Q2.20
-16%
280.4M vs 333.6M
Q4.20
-11%
321.4M vs 362.3M
Q2.21
+8%
302.8M vs 280.4M
Q4.21
+11%
356.8M vs 321.4M
Q2.22
-24%
230.8M vs 302.8M
Q4.22
-39%
217.3M vs 356.8M
Q2.23
-15%
195.1M vs 230.8M
Q4.23
-3%
211.8M vs 217.3M
Q2.24
+6%
207.6M vs 195.1M
Q4.24
-18%
174.5M vs 211.8M
Return on Equity
QoQ
Q2.21
+2%
0.02
vs 0.04
Q4.21
-33%
-0.33
vs 0.02
Q2.22
-11%
-0.11
vs -0.33
Q4.22
-31%
-0.31
vs -0.11
Q2.23
-17%
-0.17
vs -0.31
Q4.23
-45%
-0.45
vs -0.17
Q2.24
-14%
-0.14
vs -0.45
Q4.24
-15%
-0.15
vs -0.14
Institutionnal Ownership
Forecast
560%2024-Revenue
750%2024-EPS
-87%2024-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
1498.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
HKSE
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.01Â ( -2.04%)
Relative Strenght
Volume Buzz
-96%
Earning Acce
Yes
Dist 52w H.
44%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 1498.HK compares to sector?